Why Invest In Process Intensification?

Source: Sartorius

In this segment of the Bioprocess Online Live event “Upstream Process Intensification In Practice,” Susan Dexter, CTO at Sonnet Biotherapeutics joins independent consultant and process intensification pioneer Parrish Galliher for a discussion on the rationale for investing in technologies that enable intensified perfusion at Sonnet and elsewhere.

access the Video!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Bioprocess Online